Aurinia Pharmaceuticals announced Michael Hearne joined as CFO and Thomas Wei as chief scientific officer. Kyle C. Bechter ...

In the first of a three-part series, pharma brand directors discuss how their role has evolved amid the biggest marketing trends in 2026.

Kickback penalties pale in comparison to drugmaker revenue; Merck makes a $6.7 billion deal in leukemia space; Bipartisan group of senators announce $35 insulin price cap.

AbbVie is building out its Striking Out Cancer initiative, which launched last year in partnership with the Chicago Cubs ...

The demand-side platform (DSP) pushes back on Omnicom’s audit as routine oversight, even as its shares tumble around 7% in intra-day trading.

A new enforcement action from FDA signals that executive podcast appearances can be regulated like traditional ads when product claims stray beyond the label, underscoring rising scrutiny of ...

Most people who get their health coverage through the Affordable Care Act say they face sharply higher costs, with many worried they will have to pare back other expenses to cover them, according to a ...

Multiple brands have reported less than ideal results from their first few weeks of experimenting with ChatGPT Ads, citing poor CTR’s and opaque measurement capabilities.

Across the health industry, leaders are placing bets on what will endure in a time of compounding uncertainty.

State and local governments nationwide are receiving billions in opioid settlement cash over nearly two decades and are meant to spend it treating and preventing addiction.

Peptides find potential ally in RFK Jr.; Promising Lyme vaccine could face approval hurdle; Iran war may pose risk to generic and biologic drug supply and cost; White House narrows search for next CDC ...

London–based medical and scientific communications agency Obsidian Healthcare Group is expanding into the U.S. market.